Central Nervous System Damage During Cardiac Surgery Assessed by 3 Different Biochemical Markers in Cerebrospinal Fluid
- 1 January 1992
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Thoracic and Cardiovascular Surgery
- Vol. 26 (1) , 39-45
- https://doi.org/10.3109/14017439209099051
Abstract
Three cerebral biochemical markers, adenylate kinase (AK), neuron-specific enolase (NSE) and protein S-100, were determined in the cerebrospinal fluid (CSF) of male patients 24 h after coronary artery bypass grafting to investigate the extent of possible central nervous system (CNS) damage and relation to the type of oxygenator and the use of an arterial line filter. The patients were randomized into three groups for extracorporeal circulation (ECC); bubble oxygenator without an arterial line filter (Group I, n = 30), bubble oxygenator with a filter (Group II, n = 29) and a flat-sheet membrane oxygenator without a filter (Group III, n = 33). Pathologically high CSF levels of AK and NSE were found 24 h after ECC in respectively 93% and 95% of the patients. All protein S-100 concentrations were within the normal range. Isolated high CSF concentrations of AK, NSE and protein S-100 were observed in group I. Levels of AK and NSE were the lowest in group III, although there was no statistical difference between the groups. In conclusion, our study suggested that CNS damage caused by ECC involved neurons rather than glial cells. AK and NSE in the CSF seemed to be markers of ischaemic neuronal damage. Postoperative levels of biochemical markers in the CSF tended to be the lowest in the flat-sheet membrane oxygenator group.Keywords
This publication has 18 references indexed in Scilit:
- Retinal microembolism and neuropsychological deficit following clinical cardiopulmonary bypass: comparison of a membrane and a bubble oxygenator *1A preliminary communicationEuropean Journal of Cardio-Thoracic Surgery, 1989
- Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid.Stroke, 1988
- S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: A potential marker of brain damageActa Neurochirurgica, 1988
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- Cerebrospinal fluid markers in relation to outcome in patients with global cerebral ischemiaCritical Care Medicine, 1983
- Cerebrospinal fluid markers of disturbed brain cell metabolismProgress in Neurobiology, 1982
- Effect of Cardiac Glycosides on the Release of Adenylate Kinase into Cerebrospinal Fluid of Patients with Cerebral ArteriosclerosisEuropean Neurology, 1982
- Perspectives of Adenylate Kinase Activity and Glutathione Concentration in Cerebrospinal Fluid of Patients with Ischemic and Neoplastic Brain LesionsEuropean Neurology, 1982
- Assessment of Cerebral Damage During Open-Heart Surgery a New Experimental ModelScandinavian Journal of Thoracic and Cardiovascular Surgery, 1980
- Adenylate Kinase Activity and Glutathione Concentration of Cerebrospinal Fluid in Different Neurological DisordersEuropean Neurology, 1979